A phase I study of veliparib incorporated into front-line platinum based cheotherpy and bevacizumab in epithelial ovarian cancer (NCT00989651): A GOG/nrg trial Meeting Abstract

  

Authors:	Armstrong, D. K.; Moore, K. N.; Miller, A.; Bell-McGuinn, K. M.; Schilder, R. J.; Fracasso, P. M.; Walker, J. L.; Duska, L. R.; Mathews, C. A.; Chen, A. P.; O'Malley, D. M.; Gray, H. J.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Hagemann, A. R.; Aghajanian, C.
Abstract Title:	A phase I study of veliparib incorporated into front-line platinum based cheotherpy and bevacizumab in epithelial ovarian cancer (NCT00989651): A GOG/nrg trial
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	319s
Language:	English
ACCESSION:	WOS:000487345805516
DOI:	10.1200/JCO.2019.37.15_suppl.5523
PROVIDER:	wos
Notes:	Meeting Abstract: 5523 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156219